Retatrutide reduces sleep apnea severity in OSA plus obesity

Coverage, in order

1. 12h ago
   
   Healio indie peer-reviewed

   Retatrutide reduces sleep apnea severity in OSA plus obesity

   Once-weekly retatrutide lowered sleep apnea severity and improved cardiometabolic measures vs. placebo in adults with obstructive sleep apnea and obesity/overweight, according to data published in The New England Journal of Medicine. Retatrutide (Eli Lilly) is an agonist of three receptors…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.